Titterton Lewis H jr purchased $42K of ANIX
Titterton Lewis H jr purchased 12,000 shares of Anixa Biosciences Inc (ANIX) at $3.47 on 2026-07-20.
How this was made
The 30-second read
Why it matters
A new insider open-market purchase was disclosed at a specific price and share count, which can modestly influence sentiment but does not, by itself, change fundamentals.
Market read
Traders may monitor for follow-on insider activity, but the filing alone is unlikely to drive a major repricing without additional operational catalysts.
What to watch
The filing does not state intent, timing constraints, or whether the purchase is part of a broader pattern; traders should compare with prior Form 4 activity and overall volume/liquidity.
Background
This is an SEC Form 4 insider transaction for Anixa Biosciences, reported by a director.
Ticker impact
Director Titterton Lewis H jr filed a Form 4 open-market purchase of 12,000 ANIX shares at $3.4700 on 2026-07-20.
Likely limited near-term impact; may slightly support sentiment if traders treat insider buying as a signal.
Form 4 confirms a new transaction today, yet it does not include guidance, trial results, contracts, or other company-specific fundamentals that typically drive repricing.
Market effects
Minimal, as this is a single-company insider transaction without sector-wide information.
None indicated.
None indicated.
Counterpoint
Insider buys can be routine or driven by diversification, liquidity needs, or non-informational factors, especially without a 10b5-1 plan.
Key entities
- issuerAnixa Biosciences Inc
Subject of the Form 4 insider transaction, ticker ANIX.
- insiderTitterton Lewis H jr
Director who reported an open-market purchase of 12,000 shares.